SB 1750: International Drug Reference Pricing
GENERAL BILL by Gruters
International Drug Reference Pricing; Providing legislative policy; requiring prescription drug manufacturer permitholders to annually report certain international price data to the Agency for Health Care Administration; providing for administrative enforcement by a specified fine and permit suspension; requiring the agency to contract with an entity to designate reference price source countries and establish the reference prices for prescription drugs based on certain criteria; requiring the agency contractor to reevaluate the designated reference prices source countries annually and revise, as needed, etc.
Last Action: 3/8/2024 Senate - Died in Health Policy
Bill Text: Web Page | PDF
-
Bill History
Date Chamber Action 1/5/2024 Senate • Filed
1/11/2024 Senate • Referred to Health Policy; Appropriations Committee on Health and Human Services; Fiscal Policy
• Introduced
3/8/2024 Senate • Died in Health Policy
-
SB 1750, Original Filed Version (Current Bill Version) Posted 1/5/2024 at 7:59 PM
Bill Text: Web Page | PDF Analyses: None Related Bills (1)
Bill Number Subject Filed By Relationship Last Action and Location Track Bills H 1431 International Drug Reference Pricing Fine, Massullo, MD Similar Last Action: 3/8/2024 H Died in Appropriations Committee 
Citations - Statutes (4)
Citation Catchline Location in Bill Location In Bill Help 465.0244 Information disclosure. Page 5 (pdf) 499.044 Page 3 (pdf) 627.6044 Use of a specific methodology for payment of claims. Page 5 (pdf) 641.30 Construction and relationship to other laws. Page 7 (pdf)